TA220 Psoriatic arthritis - golimumab: Appendix A provisional matrix of stakeholders
|
TA220 Psoriatic arthritis - golimumab: Appendix A provisional matrix of stakeholders
17 June 2013 (38.65 Kb 11 sec) |
This page was last updated: 17 June 2013